A recombinant multi-antigen vaccine formulation containing Babesia bovis merozoite surface antigens MSA-2a1, MSA-2b and MSA-2c elicits invasion-inhibitory antibodies and IFN-γ producing cells
Authors:
- Alba Marina GimenezAGAlba Marina Gimenez
- Katia S. FrançosoKFKatia S. Françoso
- Jonatan ErschingJEJonatan Ersching
- Marcelo Y. IcimotoMIMarcelo Y. Icimoto
- Vitor OliveiraVitor Oliveira
- Anabel E. RodriguezAnabel E. Rodriguez
- Leonhard SchnittgerLeonhard Schnittger
- Monica Florin-ChristensenMonica Florin-Christensen
- Mauricio M. RodriguesMRMauricio M. Rodrigues
- Irene S. SoaresISIrene S. Soares
Open Access
- 14 November 2016
- journal article
- research article
- Published by Springer Nature in Parasites & Vectors
- Vol. 9 (1) , 1-13
Abstract
Babesia bovis is a tick-transmitted protozoan hemoparasite and the causative agent of bovine babesiosis, a potential risk to more than 500 million cattle worldwide. The vaccines currently available are based on attenuated parasites, which are difficult to produce, and are only recommended for use in bovines under one year of age. When used in older animals, these vaccines may cause life-threatening clinical symptoms and eventually death. The development of a multi-subunit recombinant vaccine against B. bovis would be attractive from an economic standpoint and, most importantly, could be recommended for animals of any age. In the present study, recombinant ectodomains of MSA-2a1, MSA-2b and MSA-2c antigens were expressed in Pichia pastoris yeast as secreted soluble peptides. The antigens were purified to homogeneity, and biochemically and immunologically characterized. A vaccine formulation was obtained by emulsifying a mixture of the three peptides with the adjuvant Montanide ISA 720, which elicited high IgG antibody titers against each of the above antigens. IgG antibodies generated against each MSA-antigen recognized merozoites and significantly inhibited the invasion of bovine erythrocytes. Cellular immune responses were also detected, which were characterized by splenic and lymph node CD4+ T cells producing IFN-γ and TNF-α upon stimulation with the antigens MSA-2a1 or MSA-2c. These data strongly suggest the high protective potential of the presented formulation, and we propose that it could be tested in vaccination trials of bovines challenged with B. bovis.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (BR)
- Instituto Nacional de Ciência e Tecnologia de Vacinas (BR)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (BR)
- Instituto Nacional de Ciência e Tecnologia de Vacinas (BR)
- Agencia Nacional de Promoción Científica y Tecnológica (AR) (PICT 2010-0438)
- Agencia Nacional de Promoción Científica y Tecnológica (AR) (PICT 2010-0438)
- CNPq/CONICET (490395/2011-2, 490395/2011-2)
- Instituto Nacional de Tecnología Agropecuaria (AR) (PNBIO 1131034)
- Instituto Nacional de Tecnología Agropecuaria (AR)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (BR)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (BR)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (BR)
This publication has 28 references indexed in Scilit:
- Validation and Field Evaluation of a Competitive Enzyme-Linked Immunosorbent Assay for Diagnosis of Babesia bovis Infections in ArgentinaClinical and Vaccine Immunology, 2012
- Immunization of Bos taurus Steers with Babesia bovis Recombinant Antigens MSA-1, MSA-2c and 12D3Transboundary and Emerging Diseases, 2010
- Babesia bovis contains an abundant parasite-specific protein-free glycerophosphatidylinositol and the genes predicted for its assemblyVeterinary Parasitology, 2010
- In silico predicted conserved B-cell epitopes in the merozoite surface antigen-2 family of B. bovis are neutralization sensitiveVeterinary Parasitology, 2010
- Perforin and Gamma Interferon Expression Are Required for CD4+and CD8+T-Cell-Dependent Protective Immunity against a Human Parasite,Trypanosoma cruzi, Elicited by Heterologous Plasmid DNA Prime-Recombinant Adenovirus 5 Boost VaccinationInfection and Immunity, 2009
- New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellinVaccine, 2008
- Potential for recombinant Babesia bovis antigens to protect against a highly virulent isolateParasite Immunology, 2005
- TheBabesia bovisMerozoite Surface Antigen 2 Locus Contains Four Tandemly Arranged and Expressed Genes Encoding Immunologically Distinct ProteinsInfection and Immunity, 2002
- Immunodominant Epitopes inBabesia bovisRhoptry-Associated Protein 1 That Elicit Memory CD4+-T-Lymphocyte Responses inB. bovis-Immune Individuals Are Located in the Amino-Terminal DomainInfection and Immunity, 2002
- Characterization of Allelic Variation in the Babesia bovis Merozoite Surface Antigen 1 (MSA-1) Locus and Identification of a Cross-Reactive Inhibition-Sensitive MSA-1 EpitopeInfection and Immunity, 2000